Immunization
Free Immunization Clinics are offered on campus periodically throughout the year.
The State of New York requires all students born on or after January 1, 1957 to present proof of immunity against measles, mumps, and rubella (MMR). (Registration is blocked until immunization proof is submitted)
Acceptable proof of immunization must include two doses of measles vaccine and one dose of mumps and rubella vaccine. All students, both degree and non-degree, who register for six or more tuition units must comply with this law. Students who are not in compliance with all immunization requirements will be excluded from classes and given an administrative withdrawal grade for all classes.
All colleges are required to distribute information about meningococcal meningitis and vaccination to all students enrolled regardless of age. Students are required to sign and submit a MENINGITIS RESPONSE FORM to demonstrate receipt of the meningococcal disease and vaccine information or a record of the immunization within the past 10 years.
Meningococcal Disease
What is meningococcal disease?
Meningococcal disease is a severe bacterial infection of the bloodstream or meninges
(a thin lining covering the brain and spinal cord).
Who gets meningococcal disease?
Anyone can get meningococcal disease, but it is more common in infants and children. For some college students, such as freshmen living in dormitories, there is an increased risk of meningococcal disease. Between 100 and 125 cases of meningococcal disease occur on college campuses every year in the United States; between 5 and 15 college students die each year as result of infection. Other persons at increased risk include household contacts of a person known to have had this disease, and people traveling to parts of the world where meningitis is prevalent.
How is the germ meningococcus spread?
The meningococcus germ is spread by direct close contact with nose or throat discharges of an infected person. Many people carry this particular germ in their nose and throat without any signs of illness, while others may develop serious symptoms.
What are the symptoms?
High fever, headache, vomiting, stiff neck and a rash are symptoms of meningococcal disease. Among people who develop meningococcal disease, 10-15% die, in spite of treatment with antibiotics. Of those who live, permanent brain damage, hearing loss, kidney failure, loss of arms or legs, or chronic nervous system problems can occur.
How soon do the symptoms appear?
The symptoms may appear two to 10 days after exposure, but usually within five days.
What is the treatment for meningococcal disease?
Antibiotics, such as penicillin G or ceftriaxone, can be used to treat people with meningococcal disease.
Is there a vaccine to prevent meningococcal meningitis?
Yes, a safe and effective vaccine is available. The vaccine is 85% to 100% effective in preventing four kinds of bacteria (serogroups A, C, Y, W-135) that cause about 70% of the disease in the United States. The vaccine is safe, with mild and infrequent side effects, such as redness and pain at the injection site lasting up to 2 days. After vaccination, immunity develops with 7 to 10 days and remains effective for approximately 3 to 5 years. As with any vaccine, vaccination against meningitis may not protect 100% of all susceptible individuals.
How do I get more information about meningococcal disease and vaccination?
Contact your family physician or your student health service. Additional information is also available on the following websites:
For more information please contact:
Health Services Center
Room MB-40
(718) 482-5280